* Instil Bio Inc TIL.OQ reported a quarterly adjusted loss
of 66 cents per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 52 cents per share.
* Reported revenue was zero; analysts expected zero.
* Instil Bio Inc's reported EPS for the quarter was a loss of 66
cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Instil Bio Inc shares had fallen by 38.4% this quarter.
* The company reported a quarterly loss of $23.13 million.
* Wall Street's median 12-month price target for Instil Bio Inc
is $31.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated May 13 at 04:21 p.m. GMT.
All figures in US dollars